![](/img/cover-not-exists.png)
Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects
Joel Morganroth, Peter C. Rüegg, Cornelia Dunger-Baldauf, Silke Appel-Dingemanse, Harald Bliesath, Martin LefkowitzVolume:
97
Year:
2002
Language:
english
DOI:
10.1016/s0002-9270(02)04343-5
File:
PDF, 140 KB
english, 2002